Professional
Added to YB: 2025-10-17
Pitch date: 2025-08-31
DXCM [bullish]
DexCom, Inc.
-2.56%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
Market Cap
$27.1B
Pitch Price
$74.17
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.11
P/E
33.71
EV/Sales
5.69
Sector
Health Care Equipment and Supplies
Category
growth
Bell Global Equities Fund New Position: DexCom, Inc.
DXCM (new position): Leading CGM technology w/ Abbott duopoly, expanding into 25M US type 2 diabetes patients (low single digit penetration targeting teens-25%). International growth opportunity. Sustained double-digit revenue growth, margin expansion driving 20%+ EPS growth.
Read full article (1 min)